296 related articles for article (PubMed ID: 33789992)
21. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
Binka M; Ooms M; Steward M; Simon V
J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
[TBL] [Abstract][Full Text] [Related]
23. Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.
Zhang Z; Gu Q; Jaguva Vasudevan AA; Hain A; Kloke BP; Hasheminasab S; Mulnaes D; Sato K; Cichutek K; Häussinger D; Bravo IG; Smits SH; Gohlke H; Münk C
Retrovirology; 2016 Jul; 13(1):46. PubMed ID: 27368163
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.
Wiegand HL; Cullen BR
J Virol; 2007 Dec; 81(24):13694-9. PubMed ID: 17913830
[TBL] [Abstract][Full Text] [Related]
25. APOBEC3-mediated restriction of RNA virus replication.
Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
[TBL] [Abstract][Full Text] [Related]
27. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.
Refsland EW; Stenglein MD; Shindo K; Albin JS; Brown WL; Harris RS
Nucleic Acids Res; 2010 Jul; 38(13):4274-84. PubMed ID: 20308164
[TBL] [Abstract][Full Text] [Related]
28. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
Langlois MA; Beale RC; Conticello SG; Neuberger MS
Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
[TBL] [Abstract][Full Text] [Related]
29. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
30. Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.
Henry M; Terzian C; Peeters M; Wain-Hobson S; Vartanian JP
PLoS One; 2012; 7(1):e30036. PubMed ID: 22272271
[TBL] [Abstract][Full Text] [Related]
31. Recurrent Loss of APOBEC3H Activity during Primate Evolution.
Garcia EI; Emerman M
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925657
[TBL] [Abstract][Full Text] [Related]
32. New World feline APOBEC3 potently controls inter-genus lentiviral transmission.
Konno Y; Nagaoka S; Kimura I; Yamamoto K; Kagawa Y; Kumata R; Aso H; Ueda MT; Nakagawa S; Kobayashi T; Koyanagi Y; Sato K
Retrovirology; 2018 Apr; 15(1):31. PubMed ID: 29636069
[TBL] [Abstract][Full Text] [Related]
33. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
[TBL] [Abstract][Full Text] [Related]
34. Differential Evolution of Antiretroviral Restriction Factors in Pteropid Bats as Revealed by APOBEC3 Gene Complexity.
Hayward JA; Tachedjian M; Cui J; Cheng AZ; Johnson A; Baker ML; Harris RS; Wang LF; Tachedjian G
Mol Biol Evol; 2018 Jul; 35(7):1626-1637. PubMed ID: 29617834
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition.
Schumann GG
Biochem Soc Trans; 2007 Jun; 35(Pt 3):637-42. PubMed ID: 17511669
[TBL] [Abstract][Full Text] [Related]
36. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
[TBL] [Abstract][Full Text] [Related]
37. Footprint of APOBEC3 on the genome of human retroelements.
Anwar F; Davenport MP; Ebrahimi D
J Virol; 2013 Jul; 87(14):8195-204. PubMed ID: 23698293
[TBL] [Abstract][Full Text] [Related]
38. The coevolution between APOBEC3 and retrotransposons in primates.
Modenini G; Abondio P; Boattini A
Mob DNA; 2022 Nov; 13(1):27. PubMed ID: 36443831
[TBL] [Abstract][Full Text] [Related]
39. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
[TBL] [Abstract][Full Text] [Related]
40. Small ruminant lentiviral Vif proteins commonly utilize cyclophilin A, an evolutionarily and structurally conserved protein, to degrade ovine and caprine APOBEC3 proteins.
Yoshikawa R; Izumi T; Nakano Y; Yamada E; Moriwaki M; Misawa N; Ren F; Kobayashi T; Koyanagi Y; Sato K
Microbiol Immunol; 2016 Jun; 60(6):427-36. PubMed ID: 27193350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
